Led · Seed · Feb 2026

Oska Health offers an AI-supported coaching platform that pairs certified health coaches with digital therapy tools to deliver continuous care for high-risk, multimorbid patients suffering from chronic kidney disease, diabetes, hypertension, and other long-term conditions. Through video calls, chat, and a dedicated app, coaches translate physicians’ recommendations into day-to-day actions, aiming to boost medication adherence, strengthen health literacy, and lower avoidable hospitalisations. The company’s proprietary AI augments care teams by triaging patient needs and reducing administrative workload, making personalised chronic-care support scalable. Operating for more than three years, Oska Health has demonstrated its ability to keep patients engaged between medical appointments. The newly raised capital will fund further expansion of its AI infrastructure and broaden access to its hybrid care model across Europe. Financial details beyond the recent seed round have not been disclosed.

Led · Seed · Feb 2026

Founded in 2023, Hemi Health combines multidisciplinary clinical expertise with a proprietary digital platform and mobile app to deliver personalised diagnostics, treatment plans, continuous monitoring and coordinated care for complex chronic and neuroplastic pain conditions. Initially focused on migraine and headache disorders, the company has broadened its scope to concussion and whiplash care, operating through both physical clinics in Frederiksberg, Middelfart and Aarhus and virtual video consultations. More than 1,000 patients have used its structured treatment model to date. The HEMI app lets users track symptoms in a digital diary and connect with specialists, and the company collaborates with several insurance providers to integrate its services. Fresh funding will support international expansion starting with the Netherlands and accelerate development of the AI-enabled care platform. Management believes AI can turn fragmented, multi-year care journeys into structured programmes with measurable outcomes, positioning Hemi Health for growth in insurance-driven healthcare markets.

Participated · Series A · Jul 2024

deepc is a Munich-based company that builds an AI operating system for radiologists and enterprise clinical organizations. Its flagship platform, deepcOS®, gives clinicians access to a marketplace of regulatory-approved AI solutions across more than 60 clinical indications, aiming to improve workflow efficiency and assist radiologists in routine tasks. The company provides installation, end-to-end integration, unified contracting and billing, and service under a comprehensive privacy and security framework. Led by CEO Dr. Franz Pfister, deepc plans to use recent funding to accelerate growth and international expansion and to further enhance and commercialize its operating system. Financially, deepc closed its Series A with a $13M extension that brought the Series A total to $30M. Investors on the extension included Sofinnova Partners and Bertelsmann Investments, with participation from KHP Ventures, SwissHealth Ventures and existing backer Winning Mindset Ventures. deepc develops deepcOS®, a cloud-native, vendor-neutral operating system that integrates third-party AI into existing radiology workflows. The platform allows approved AI vendors an efficient route to commercialize their solutions and offers hospitals and clinics a secure, one-stop shop for AI-assisted radiology. Led by co-founder and CEO Franz Pfister, deepc aims to give healthcare systems flexibility to adopt and integrate third-party AI technology while improving patient outcomes. The company plans to use the new funds to develop additional features and expand commercialization of deepcOS®. deepc is based in Munich, Germany. The company recently completed a significant financing to support product development and go-to-market expansion.

Led · Equity · Dec 2020

OnlineDoctor operates a teledermatology platform where patients submit skin concerns and receive diagnoses and action recommendations from specialist dermatologists. The platform already reaches Switzerland, Germany and Austria and hosts over 600 specialist doctors from the DACH region. In Germany more than 10 million statutory insured can access the service free of charge. Customers include hospitals, clinics, over 300 pharmacies, health insurers and international companies such as Hartmann and L'Oréal. Growth was accelerated by the COVID-19 pandemic; the company plans to use new capital to internationalize, scale growth and further develop the platform technically. Teams in St. Gallen, Zürich and Hamburg will be expanded; the company raised CHF5.5 million in the recent financing and has cumulatively attracted over CHF8 million in venture capital. OnlineDoctor is a Swiss telemedicine startup founded in 2016 that offers photo-based dermatology assessments. Users select a dermatologist, answer questions via a proprietary chatbot, upload three photos and pay a €39 fee. The service delivers an initial specialist assessment and treatment recommendation within 48 hours. Collected data are encrypted and stored exclusively on German servers. The company had previously operated only in Switzerland and is now expanding into the German market. In Germany it already works with 150 dermatologists, and management sees significant growth potential. Investors have provided CHF 2.5 million to date. OnlineDoctor is a St. Gallen–based teledermatology platform that enables patients to send encrypted smartphone photos of suspicious skin lesions to specialists. Patients receive professional advice within 48 hours. The startup won the Best of Swiss Web Award in the mobile category and was a gold winner at the ceremony in Zurich. The company was founded last year by a team led by dermatologist E. Paul Scheidegger. In January the St. Gallen team completed a CHF600,000 financing round.